Prevalencija najčešćih spoljašnjih manifestacija i komorbiditeta kod muškaraca obolelih od dekompenzovane alkoholne ciroze jetre
Sažetak
Uvod/Cilj. Spoljašnje manifestacije i komorbiditeti predstavljaju važne kliničke aspekte dekompenzovane alkoholne ciroze jetre (ACJ), pružajući uvid u težinu bolesti i sistemsko zahvatanje. Cilj rada bio je da se ispita učestalost spoljašnjih znakova i komorbiditeta kod bolesnika muškog pola obolelih od dekompenzovane ACJ. Metode. Sprovedena je prospektivna, komparativna, opisna i analitička studija na Klinici za internu medicinu, Univerzitetskog kliničkog centra Republike Srpske u Banja Luci, Bosna i Hercegovina. Istraživanje je obuhvatilo 123 bolesnika muškog pola kojima je postavljena dijagnoza dekompenzovane ACJ. Sve neophodne dijagnostičke procene, uključujući laboratorijske, mikrobiološke, serološke, radiološke i endoskopske preglede, obavljene su tokom njihove prve hospitalizacije. Rezultati. Prosečna starost bolesnika iznosila je 59,09 ± 9,32 godina. Najčešće spoljašnje manifestacije bile su žutica (79,67%), paučinaste vene (54,47%), palmarni eritem (36,58%) i ginekomastija (18,69%). Najčešći komorbiditeti bili su dijabetes melitus (19,51%), kongestivna srčana insuficijencija (17,88%) i hronična bubrežna bolest (11,38%). Ustanovljena je značajna korelacija između težine bolesti i prisustva spoljašnjih znakova, pri čemu je žutica bila najzastupljenija. Zaključak. Spoljašnje manifestacije i komorbiditeti su česti kod bolesnika muškog pola obolelih od ACJ, što odražava sistemski uticaj bolesti. Prepoznavanje ovih kliničkih pokazatelja može doprineti ranijoj dijagnozi, stratifikaciji rizika i prilagođenim terapijskim strategijama.
Reference
World Population Review. Alcohol consumption by country 2025 [Internet]. Lancaster: WPR; 2025 (accessed 2025 April 28). Available from: https://worldpopulationreview.com/country-rankings/alcohol-consumption-by-country
World Health Organization. Over 3 million annual deaths due to alcohol and drug use, majority among men [Internet]. Geneva: WHO; 2024 (accessed 2025 April 28). Available from: https://www.who.int/news/item/25-06-2024-over-3-million-annual-deaths-due-to-alcohol-and-drug-use-majority-among-m
en
Niu X, Zhu L, Xu Y, Zhang M, Hao Y, Ma L, et al. Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis. BMC Public Health 2023; 23(1): 859. Erratum in: BMC Public Health 2023; 23(1): 1380.
Osna NA, Donohue TM Jr, Kharbanda KK. Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Res 2017; 38(2): 147−61.
Julien J, Ayer T, Tapper EB, Chhatwal J. The Rising Costs of Alcohol-Associated Liver Disease in the United States. Am J Gastroenterol 2024; 119(2): 270−7.
Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol 2023; 79(2): 516−37.
Roerecke M, Vafaei A, Hasan OSM, Chrystoja BR, Cruz M, Lee R, et al. Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2019; 114(10): 1574−86.
Patel R, Mueller M. Alcohol-Associated Liver Disease [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 (accessed 2025 April 28). Available from: https://www.ncbi.nlm.nih.
gov/books/NBK546632/
Liu Y, Zhao Y, Gao X, Liu J, Ji F, Hsu YC, et al. Recognizing skin conditions in patients with cirrhosis: a narrative review. Ann Med 2022; 54(1): 3017−29.
Bhandari A, Mahajan R. Skin Changes in Cirrhosis. J Clin Exp Hepatol 2022; 12(4): 1215−24.
Tapper EB, Parikh ND. Diagnosis and Management of Cirrhosis and Its Complications: A Review. JAMA 2023; 329(18): 1589−602.
García-Compeán D, Orsi E, Kumar R, Gundling F, Nishida T, Villarreal-Pérez JZ, et al. Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives. World J Gastroenterol 2022; 28(8): 775−93.
Dugum M, McCullough A. Diagnosis and Management of Alcoholic Liver Disease. J Clin Transl Hepatol 2015; 3(2): 109−16.
Mirowski K, Balicka-Ślusarczyk B, Hydzik P, Zwolińska-Wcisło M. Alcohol-associated liver disease - a current overview. Folia Med Cracov 2024; 64(2): 93−104.
Liu YB, Chen MK. Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions. World J Gastroenterol 2022; 28(41): 5910−30.
Bokan G, Kovacevic M, Zdravkovic N, Bokonjic D, Kovacevic M, Prodanovic V, et al. Significance of Laboratory Findings and Esophageal Varices in Male Patients With Decompensated Alcoholic Liver Cirrhosis: A Single-Center Experience. Cureus 2025; 17(1): e78274.
Sharma P, Arora A. Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis. Transl Gastroenterol Hepatol 2020; 5: 19.
Ray G, Manjubhargav P. Clinical Presentation and Mortality Determinants of Alcohol-Related Liver Disease: A Single-Center Experience of the Rising Menace from Eastern India. Inflamm Intest Dis 2019; 4(3): 104−14.
Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am Fam Physician 2006; 74(5): 756−62.
Nilsson E, Anderson H, Sargenti K, Lindgren S, Prytz H. Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden: a 10-year population-based study. Aliment Pharmacol Ther 2016; 43(12): 1330−9.
Adachi M, Brenner DA. Clinical syndromes of alcoholic liver disease. Dig Dis 2005; 23(3−4): 255−63.
Li H, Wang R, Méndez-Sánchez N, Peng Y, Guo X, Qi X. Impact of spider nevus and subcutaneous collateral vessel of chest/abdominal wall on outcomes of liver cirrhosis. Arch Med Sci 2019; 15(2): 434−48.
Coman LI, Coman OA, Bădărău IA, Păunescu H, Ciocîrlan M. Association between Liver Cirrhosis and Diabetes Mellitus: A Review on Hepatic Outcomes. J Clin Med 2021; 10(2): 262.
Milić S, Lulić D, Štimac D, Ružić A, Zaputović L. Cardiac manifestations in alcoholic liver disease. Postgrad Med J 2016; 92(1086): 235−9.